A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The study is divided in 3 parts, starting with the safety assessment of BPR277 ointment in
Healthy volunteers (Part 1). If found to be well tolerated in Part 1, BPR277 ointment will be
assessed in two different patients groups to evaluate safety and efficacy in atopic
dermatitis (Part 2) and in Netherton syndrome (Part 3).